Herein, we review and provide an update on the role of CLRs in the regulation of type 2 immune responses to allergens and discuss the most relevant findings related to the potential therapeutic applications of CLR ligands for treatment of allergic diseases. This evidence concerns the gene DCLK3 and allergic disease.